Switch View
© PR Newswire
09.10.2025
ISIN: US0390141051
Arcadia Biosciences Inc
RKDA
LISTED
NASDAQ
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: FR0000061129
Boiron SA
BOI
LISTED
EURONEXT
BOIRON : Déclaration des droits de vote au 30 septembre 2025
News Preview
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF)
Date d'arrêt des informations
Nombre total d'actions composant le capital
Nombre total de droits de vote...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned Hindlemann v. Molina Hea...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© EQS Newswire
09.10.2025
ISIN: DE0005227235
Biotest AG
BIO3
LISTED
XETR
Biotest’s Yimmugo® launches in the United States
News Preview
PRESS RELEASE
Biotest’s Yimmugo® launches in the United States
Dreieich, Germany, October 9, 2025. Biotest AG, a specialist in innovative haematology, clinical immunology and intensive care medicine and part of Grifols, a global healthcare company and leading producer of plasma-derived medicines, proudly announces the official launch of Yi......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
09.10.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development's portfolio company PharmNovo receives approval to initiate a phase 2a trial of its drug candidate PN6047 in Spain
News Preview
STOCKHOLM, SWEDEN – October 9, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company PharmNovo has received approval from the Spanish regulatory authorities to initiate a phase 2a clinical trial of its drug candidate, PN6047, being developed as a treatment for neuropathic pain. The trial will be conduct...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Oct. 9, 2025 /PRNewswire/ -- The Ademi Firm is investigating Akero (NASDAQ: AKRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Novo Nordisk....
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems to Webcast Third Quarter 2025 Conference Call
News Preview
Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its third quarter 2025 conference call.
The Company will issue a press release announcing its results on Thursday, October 23, 2025, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) code for procedures involving its CARTIHEAL AGILI-C Cartilage Repair Implant, effective January 1, 2027. ...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
News Preview
TIME Best Inventions honors extraordinary innovations changing lives
DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: US63633D1046
National Health Investors Inc
NHI
LISTED
NYSE
NHI Announces Third Quarter 2025 Earnings Release and Conference Call Dates
News Preview
MURFREESBORO, TN / ACCESS Newswire / October 9, 2025 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2025. NHI plans to issue its earnings release after the market closes on Thursday, November 6, 2025, and will host a conference call on the following day, Friday...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US12482W4087
cbdMD Inc
YCBD
LISTED
XASE
cbdMD's Herbal Oasis Expands its Florida Footprint with Bevtalk Distribution Partnership
News Preview
CHARLOTTE, N.C., Oct. 9, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill–compliant Delta-9 offerings, today announced that its Herbal Oasis hem...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025
News Preview
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
09.10.2025
ISIN: US12674W1099
Cabaletta Bio Inc
CABA
LISTED
NASDAQ
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
News Preview
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory patients; all three patients remained off immunomodulators since infusion and are off or tapering steroids as of the data cut-off –...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
News Preview
Announcement no. 09/2025Inside information ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia launches an offering of registered shares – to fund the company to overall profitability
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US85789A1051
Stealth BioTherapeutics Corp
MITO
LISTED
NASDAQ
Stealth BioTherapeutics Announces Mito Assist™ Patient Support Program and Specialty Pharmacy Partnership with AnovoRx to Distribute FORZINITY™(elamipretide) injection
News Preview
Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community
NEEDHAM, Mass., Oct. 9, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US28106W1036
Editas Medicine Inc
EDIT
LISTED
NASDAQ
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
News Preview
Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Masimo to Host Investor Day on December 3, 2025
News Preview
Masimo (NASDAQ: MASI) today announced it will host a meeting with the analyst and investor community at 9:00am PT on Wednesday, December 3, 2025.
Presentations will be led by select members of the Executive Leadership Team and will cover an overview of the company’s business, market opportunities, innovation pipeline, commercial growth strategy,...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how rigorous standards, continuous monitoring, and customer-centered design are shaping the future of safe and effective telehealth.
“At Hims & Hers, we believe that digi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CNE100003N76
Shanghai Henlius Biotech, Inc.
2696
LISTED
HKSE
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission
News Preview
The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission
World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperative sett...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Investors who lost money on Lantheus Holdings, Inc.(LNTH) should contact The Gross Law Firm about pending Class Action - LNTH
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
The Gross Law Firm Notifies Shareholders of Semler Scientific, Inc.(SMLR) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NUTX
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purch...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class Action - SVRA
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased s...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY).
Shareholder...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, Oct. 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: CA4576377002
InMed Pharmaceuticals Inc.
INM
LISTED
NASDAQ
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. Neil Klompas, CPA, CA to its...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to provide testing and contract research organization (CRO) services in s...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US42227W2070
Healthcare Triangle Inc
HCTI
LISTED
NASDAQ
Healthcare Triangle Takes Bold Step toward AI-Driven Future with the Signing of a Non-Binding LOI for the Acquisition of Teyame.AI, which is on track to generate $34M in Revenue for fiscal year 2025 and would create for Healthcare Triangle a Next-Generati
News Preview
PLEASANTON, Calif., Oct. 9, 2025 /CNW/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced it has signed a non-binding Letter of Intent (LOI) to acquire the assets of Teyame.AI LLC ("Teyame"), a Spain...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US42227W2070
Healthcare Triangle Inc
HCTI
LISTED
NASDAQ
Healthcare Triangle Takes Bold Step toward AI-Driven Future with the Signing of a Non-Binding LOI for the Acquisition of Teyame.AI, which is on track to generate $34M in Revenue for fiscal year 2025 and would create for Healthcare Triangle a Next-Generati
News Preview
PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced it has signed a non-binding Letter of Intent (LOI) to acquire the assets of Teyame.AI LLC ("Teyame"),...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CNE100003N76
Shanghai Henlius Biotech, Inc.
2696
LISTED
HKSE
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission
News Preview
The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission
World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperative sett...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US3179701012
Firefly Neuroscience, Inc.
AIFF
LISTED
NASDAQ
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Firefly Neuroscience, Inc. (NASDAQ: AIFF) on behalf of the company's shareholders. The investigation seeks to determine whether Firefly Neuroscience's directors breached their fiduciary duties in connection with...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Opill® Nails It with First-Ever Brand Collaboration, Launching 'Opill and Chill' With Chillhouse
News Preview
Brands Will Donate One Pack of Opill® to NY Birth Control Access Project for Each Opill®-Themed Chill Tips Set Sold
GRAND RAPIDS, Mich., Oct. 9, 2025 /PRNewswire/ -- Today, Perrigo Company plc (NYSE: PRGO), a leading provi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst Moisturizer
News Preview
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica®'s new packaging features a refreshed logo, modernized look, and luxe copper color palette.
The brand's new HA5® moisturizer
is designed to support...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced publication of its 2025 Post-Market Surveillance (PMS) Report. The report is being released ahead of the annual meeting of the American Society of Pl...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present two posters at the Canadian Society of Allergy and Clinical Immunology (CSACI) 80th Anniversary Scientific Meeting, taking place October 15-18, 2025 in Vancou...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akero Therapeutics, Inc. (NASDAQ: AKRO) to Novo Nordisk A/S is fair to Akero shareholders. Under the terms of the proposed transaction, Akero shareholders will receive $54.00 per share in cash, and a non-transferable Contingent Value Right entitling its holder to r...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the Autism Partnership Program to expand access to its industry leading exome and genome testing – the only autism testing program committed to delivering answers to families in weeks. Jaguar Gene Therapy joins the program as the foundin...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare unveils Carestation 850 at ANESTHESIOLOGY 2025: its next-generation anesthesia delivery system designed to adapt to care needs
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the unveiling of Carestation™ 850, its next-generation, FDA 510(k) pendingi anesthesia delivery system that is designed to help care teams adapt to evolving clinical and operational needs. Marking the latest evolution of GE HealthCare’s Carestation portfolio, Carestation 850 has the potential to advance...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting
News Preview
Overall survival recognized as key efficacy endpoint in osteosarcoma, where no standard of care existsRapporteur highlights potential broader benefits of OST-HER2 in pulmonary and primary osteosarcoma settings, supported by translational canine data from the University of PennsylvaniaNew York, New York--(Newsfile Corp. - October 9, 2025) - OS Thera...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: CA74447P1009
Psyched Wellness Ltd
PSYC
LISTED
CSE
Psyched Wellness Provides Comprehensive Investor Update
News Preview
Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to provide the following corporate update to i...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting
News Preview
ROCKVILLE, Md., Oct. 9, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present interim data from the Phase II ALTITUDE® trial evaluating suprachoroidal delivery of surabgene lomparvovec (ABBV-RGX-314, sura-vec) for the treatment of diabetic retinopathy (DR) at the American Academy...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Biopharma Leaders Advance the Future of Life Sciences at Veeva Commercial Summit Europe
News Preview
Industry gathers to explore Veeva AI innovations and exchange ideas with companies including Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna, and MSD
BARCELONA, Spain, Oct. 9, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Ast...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US74019P1084
Precision BioSciences Inc
DTIL
LISTED
NASDAQ
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases
News Preview
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the publication of a peer-reviewed manuscript titled “High-Efficiency Homology-Directed Insertion into the Genome using the Enginee...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IL0011595993
InMode Ltd.
INMD
LISTED
NASDAQ
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
News Preview
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time
YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the thir...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CA29668H1047
Essa Pharma, Inc.
EPIX
LISTED
NASDAQ
ESSA Announces Completion of Arrangement with XenoTherapeutics
News Preview
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /CNW/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics' ("Xeno") previously announced acquisition of ESSA (the "Acquisition").
Xeno Acquisition Corp., a wholly own...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CA29668H1047
Essa Pharma, Inc.
EPIX
LISTED
NASDAQ
ESSA Announces Completion of Arrangement with XenoTherapeutics
News Preview
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics' ("Xeno") previously announced acquisition of ESSA (the "Acquisition").
Xeno Acquisition Corp., a who...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: GB00BP6S8Z30
Oxford Nanopore Technologies PLC
ONT
LISTED
LSE
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
News Preview
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit
Establishes a framework to define and propose future portfolios
Extends collaboration through 2032, reinforcing Bio-Techne's...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden™ Registrational Trial in Q4 2025
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the Company has completed discussions with the U.S. Food and Drug Administration (FDA) on its Embolden™ registrational trial protocol and plans to initiate dosing...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Announces First-Quarter 2026 Results
News Preview
Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter ended August 31, 2025.
“I see tremendous opportunity ahead to leverage Neogen’s strong, longstanding leadership in food and animal safety,” said Mike Nassif, Neogen’s Chief Executive Officer and President. “Few companies are as well-positioned as we are to help sh...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and prevention pipeline at the 20th European AIDS Conference (EACS 2025) taking place Oct.15-18, 2025, in Paris, France. The company’s presentations will include:
An oral presentation of weight and bo...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
News Preview
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 abstracts across more than 20 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be presented at the European Society for Medical Oncology (ESMO) Congress 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US00688A2050
Adial Pharmaceuticals Inc
ADIL
LISTED
NASDAQ
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
News Preview
Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
News Preview
CORAL GABLES, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for people living with rare and difficult-to-treat diseases, today announced that data developed by or in conjunction...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
